Tenderwize
Back to tender search

Non-exclusive discount agreement for Naloxegol

GWQ ServicePlus AG·Düsseldorf, Germany·Deadline Aug 10, 2027 · 357 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Naloxegol -VV 86

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Submission method is postal only; electronic submission is explicitly not allowed.

No contract value or volume information is provided, so revenue potential cannot be assessed from the notice.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Supply of pharmaceutical products related to the active substance Naloxegol.
  • Conclusion of a non-exclusive discount agreement under Section 130a(8) SGB V.
Show full summary

Open supply procedure by GWQ ServicePlus AG for a non-exclusive discount agreement under Section 130a(8) SGB V for the active substance Naloxegol. The notice indicates a postal submission process, no electronic submission, and a contract start on 2025-10-01. No contract value is stated. The tender appears to be a single-lot arrangement with document access via the GWQ portal, but the extracted XML notice is the only procurement document text provided.

Risks

Submission method is postal only; electronic submission is explicitly not allowed.

No contract value or volume information is provided, so revenue potential cannot be assessed from the notice.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Provide a list of the PZN covered by the contract (Annex 2).
  • Provide proof of marketing authorization via an extract from the public part of the AMIce database.

Administrative

  • Submit a signed contract in duplicate.

Buyer

Location

Düsseldorf, DEU

Buyer profile

Open profile

Identifier

DE258895210

Activity

Health

Lots (1)

LOT-0000

Non-exclusive discount agreement for Naloxegol

Single lot for concluding a non-exclusive rebate/discount agreement for the active substance Naloxegol under Section 130a(8) SGB V. The agreement is open to interested companies under the same conditions during the contract term. The document text states that participating sickness funds may vary by specialty lot, but only one lot is structured here, so lot-level variation is not further specified.

SuppliesEU fundedElectronic submission

Location

DEA11, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Aug 10, 2027

Procurement Details

Publication date
18 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
540952-2025

Documents (1)

Similar tenders